Les communiqués de presse sont publiés par FUJIFILM Corporation au Japon.
Fujifilm ne garantit pas la distribution des produits présentés dans ses communiqués de presse dans tous les pays et régions du monde.
Veuillez noter que le contenu de ce site Web est à jour à la date de publication du communiqué de presse. Il peut être modifié ensuite sans préavis. Les informations des communiqués telles que la disponibilité du produit, les caractéristiques, les prix et les contacts, sont conformes à celles que nous détenons au moment de la publication.
- Jan 6, 2023
- FUJIFILM Cellular Dynamics Announces License Agreement with Novo Nordisk for the Development of iPSC-Derived Cell Therapies
- Déc 13, 2022
- Fujifilm to Build an Advanced Semiconductor Materials Manufacturing Facility in South Korea
- Nov 22, 2022
- Fujifilm Invests $188 Million in New Cell Culture Media Manufacturing Facility
- Oct 19, 2022
- Fujifilm develops “FUJINON HZK25-1000mm”
- Oct 6, 2022
- Fujifilm to establish its first Bio-CDMO site in Japan
- Oct 3, 2022
- Fujifilm to establish a local subsidiary in South Korea to accelerate business growth of cell culture media
- Sep 8, 2022
- Fujifilm announces a strategic investment in a new production facility in Kumamoto Japan to support the fast-growing semiconductor industry
- Jul 6, 2022
- Fujifilm launches FUJIFILM PROJECTOR Z6000
- Jul 1, 2022
- Fujifilm launches world’s first mobile app “FUJIFILM Prescale Mobile” that quantifies pressure based on color development on pressure measurement film
- Jun 30, 2022
- Fujifilm to Invest USD 1.6 billion to enhance and expand its global offering of cell culture manufacturing services
- Jun 8, 2022
- Fujifilm Acquires European Inkjet System Integrator UNIGRAPHICA to Expand Inkjet Integration Business Globally
- Mai 9, 2022
- Fujifilm reveals FUJIFILM PROJECTOR Z6000
- Avr 5, 2022
- Fujifilm Completes Acquisition of a Dedicated Cell Therapy Manufacturing Facility from Atara Biotherapeutics, Inc.
- Mar 29, 2022
- Fujifilm Completes Acquisition of Shenandoah Biotechnology
- Mar 28, 2022
- Fujifilm Invests in a new manufacturing facility for inkjet pigment dispersions in the U.S.
- Mar 23, 2022
- Fujifilm to Acquire Shenandoah Biotechnology, Leading Manufacturer of Recombinant Proteins
- Jan 26, 2022
- Fujifilm Expands its Advanced Therapies CDMO Business with the Acquisition of a Dedicated Cell Therapy Manufacturing Facility from Atara Biotherapeutics, Inc.
- Déc 8, 2021
- Fujifilm Kicks Off Operations at its New, State-of-the-Art Cell Culture Media Manufacturing Facility in Europe
- Déc 1, 2021
- FUJIFILM Irvine Scientific Establishes a Bioprocessing Innovation and Collaboration Center in China (FUJIFILM Irvine Scientific)
- Oct 20, 2021
- Fujifilm launches 4K-compatible broadcast lens with 107× zoom “FUJINON UA107x8.4BESM”